EWALL-INO Archives - Medical Conferences

EWALL-INO: Inotuzumab ozogamicin promising as first-line therapy for BCP-ALL

Presented By

Prof. Patrice Chevallier, Nantes University Hospital, France

Trial

Phase 2, EWALL-INO

Conference

ASH 2021

Type

Peer-reviewed article

4 February 2022 11:57

site created by:

HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com